PacBio (PACB) announced the appointment of Chris Smith to its Board of Directors, effective today. Smith is currently the Chief Executive Officer of NeoGenomics (NEO).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- PacBio announces role in study to be published in Nature Genetics
- Largest borrow rate increases among liquid names
- PacBio announces GIFS at USask as first Revio PacBio CSP in Canada
- PacBio, Radboud UMC announces study results using HiFi long read sequencing
- PacBio reports Q4 preliminary revenue $39.2M, consensus $40.63M